TIMOTHY LILES-RAMOS: Open Payments
NPI 1851884944 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 76 payments from 18 companies in 2025. Trend: 2023 $2,031 · 2024 $2,042 · 2025 $1,812
Food & beverage: $1,732Education: $80
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 14 | $342 |
| ABBVIE INC. | 11 | $274 |
| Insmed, Inc. | 10 | $234 |
| Melinta Therapeutics, LLC | 6 | $205 |
| Paratek Pharmaceuticals, Inc. | 11 | $138 |
| Merck Sharp & Dohme LLC | 5 | $127 |
| Aimmune Therapeutics, Inc. | 5 | $104 |
| Astellas Pharma US Inc | 1 | $80 |
| Gilead Sciences, Inc. | 3 | $69 |
| La Jolla Pharmaceutical Company | 2 | $64 |
Products named: CABENUVA, Arikayce, Rezzayo, NUZYRA, MAVYRET, EMBLAVEO, VOWST, ZERBAXA.
Industry payments across FL — which companies pay providers there.
